CPC DISTRIBUTION CHROMATOGRAPHY OF CANNABINOIDS
Patent Information
- Application Number
- DE502016016793
- Authority / Receiving Office
- DE · DE
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2015-02-27
- Filing Date
- 2016-02-29
- Publication Date
- 2024-11-28
- Estimated Expiration
- 2036-02-29
AI Technical Summary
Current methods for extracting cannabinoids, such as THC and CBD, from cannabis extracts using Centrifugal Partition Chromatography (CPC) face challenges in achieving high purity and yield, with prior art methods achieving maximum purities of around 93.1% and requiring multiple steps, while also using neurotoxic solvents like hexane.
A method utilizing a two-phase solvent system with cyclohexane, n-heptane, or iso-octane as the stationary phase and acetonitrile as the mobile phase, with optional addition of t-butyl methyl ether, which enhances separation performance, achieving purities over 95% and reducing the need for additional chromatographic steps, and allows for easy renewal of the stationary phase.
This method achieves high purity and yield of cannabinoids, often exceeding 95%, with reduced process stages and minimal eluent consumption, enabling efficient industrial-scale extraction with minimal solvent toxicity and no deposition on the stationary phase.
Description
[0001] The invention relates to cannabinoids and their isolation and purification as well as extraction by means of Centrifugal Partition Chromatography (short: CPC).
[0002] CPC is used for the extraction and enrichment of plant constituents from plant extracts on analytical, semi-preparative, and preparative scales. CPC is a liquid-liquid chromatography method that typically uses a two-phase solvent system.
[0003] It enables the virtually loss-free separation of highly complex substance mixtures from crude extracts. Manufacturers of such centrifugal partition chromatographs for CPC include Kromaton Sarl (Annonay, FR) and Armen Instrument Sas (Saint-Avé, FR).
[0004] Compared to liquid chromatography (HPLC), CPC is simpler and more cost-effective because matrix effects and irreversible adsorption on solid phases do not occur.
[0005] The CPC method, like common liquid-liquid chromatography methods such as high-speed countercurrent chromatography (HSCCC), uses a two-phase solvent mixture. Either the upper or lower phase can be used as the stationary phase. Unlike HSCCC, however, CPC does not use a capillary coil, but rather a rotor equipped with several hundred separation chambers. In these chambers, arranged directly one after the other, the substances contained in the plant extract are distributed between the mobile and stationary phases.
[0006] The system is set into rapid rotation (up to 2,500 rpm) during the separation process. This not only retains the desired phase in the CPC rotor, depending on the flow direction, but also accelerates the separation of the two phases through centrifugal force. This allows for high flow rates and, consequently, the throughput of large amounts of substance in a short time, thus enabling preparative applications of this separation technique.
[0007] The partition coefficient K of the desired substance between the two phases should be between 0.7 and 4.5. At lower K values, the substance elutes too quickly, making separation impossible. At higher K values, however, the retention time becomes too long for the rapid purification of large quantities of a plant extract.
[0008] The prior art describes that cannabinoids can be obtained from cannabis extracts using CO2 extraction (DE10051427C1). However, cannabinoids such as THC (A, "dronabinol") or CBD (B, cannabidiol) are not obtained in absolute purity. Fig. 1: Dronabinol (A) ((6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol, Δ 9< -tetrahydrocannabinol (Δ 9< THC)), cannabidiol (CBD) (B) ((2-[1R-3-Methyl-6-(1-methylethenyl]-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol))
[0009] The chromatographic separation and preparative purification of cannabinoids remains a challenge, especially the extraction of cannabinoids, preferably Δ 9< THC and CBD, in high purity of more than 95%.
[0010] In the prior art, Hazekamp, A., 2007, Doctoral thesis, Leiden University and Arno Hazekamp, Ruud Simons, Anja Peltenburg-Looman, Melvin Sengers, Rianne van Zweden, Robert Verpoorte, Preparative isolation of cannabinoids from Cannabis sativa by centrifugal partition chromatography, J. Liq. Chrom. Rel. Technol. 2004, 27(15): 2421-2439, describe the preparative isolation of cannabinoids using CPC. However, the prior art uses a two-phase system based on hexane and achieves a maximum purity of 93.1%. Furthermore, low yields are achieved. Furthermore, hexane is a neurotoxin of solvent class 2 (ICH Guidelines).
[0011] The object is therefore to provide an improved process for the separation and / or purification of cannabinoids from cannabis plant extracts, which at least partially eliminates the existing disadvantages and is in particular capable of providing a higher yield and purity of cannabinoids, in particular CBD and / or THC, in many applications.
[0012] The problem is solved by a method according to one of the patent claims.
[0013] The density and viscosity of cyclohexane, n-heptane and iso-octane are greater than the density / viscosity of n-hexane, so that a more stable two-phase system is produced compared to a second mobile phase such as acetonitrile, for example, enabling better retention of the stationary phase and consequently achieving increased separation efficiency, so that higher purity and yield are always achieved compared to n-hexane; with purities of over 95%, even 99%. The process according to the invention and / or the use according to the invention advantageously show low eluent consumption and no deposits on a stationary phase, so that no regeneration of the stationary phase or treatment or removal of interfering components is necessary. The product recovery is almost quantitative because the stationary and mobile phases can simply be interchanged.In addition, the stationary phase is completely renewed with each run and can be easily purified or renewed by distillation. The purity of the isolated cannabinoids is often so high that further chromatographic purification steps are unnecessary. The process can also be easily carried out on an industrial scale. The yield of cannabinoids is often greatly increased compared to the state of the art, as will be explained in more detail below. The number of required process steps can usually be significantly reduced compared to alternative techniques. The extraction of cannabinoids from any cannabis plant and their extracts can be particularly advantageous. This includes cannabis extracts from cannabis plants. (Cannabis sativa, Cannabis indica, Cannabis ruderalis), such as hemp, industrial hemp, useful hemp, drug hemp, fiber hemp, etc.
[0014] For example (and not according to the invention), for cannabinoids, the advantageous use of the two immiscible solvents acetonitrile and heptane is provided at a flow rate of 50 to 600 mL per minute, preferably at a flow rate of 200 to 300 mL per minute during separation and a maximum flow rate during rinsing, at a rotation speed of 50 to 1,500 rpm, preferably at a rotation speed of 900 to 1,100 rpm during separation. Furthermore, the use of the upper phase as the stationary phase is preferred.
[0015] In a further preferred embodiment, t-butyl methyl ether (TBME) can be added to the respective solvent, namely 1 to 15% (v / v), preferably 9 to 13% (v / v).
[0016] The second immiscible liquid phase may also comprise solvents such as methanol (according to the invention), ethyl acetate (not according to the invention), or water (not according to the invention), optionally mixed with 1-15% t-butyl methyl ether (TBME). Examples of solvent systems are not exhaustive (stationary phase / mobile phase): n-Heptane / Acetonitrile 1:1 (without t-butyl methyl ether) (not according to the invention), n-Heptane / Ethyl acetate / Acetonitrile (not according to the invention), n-Heptane / Ethyl acetate / t-butyl methyl ether / Acetonitrile (not according to the invention), n-Heptane / Ethyl acetate / Methanol / Water, n-Heptane / Methanol / Water, n-Heptane / Ethanol / Water (not according to the invention), n-Heptane / Acetone / Water (not according to the invention), n-Heptane / Methanol / Acetonitrile, n-Heptane / Ethanol / Acetonitrile (not according to the invention), n-Heptane / Acetone / Acetonitrile (not according to the invention), n-Heptane / Chloroform / Acetonitrile (not according to the invention), n-Heptane / Chloroform / Methanol, n-Heptane / Methanol, n-Heptane / Ethanol / Methanol, n-Heptane / n-Butanol / Acetonitrile (not according to the invention), n-Heptane / 2-Propanol / Water (not according to the invention), n-Heptane / n-Propanol / Water (not according to the invention), n-Heptane / 2-Propanol / Acetonitrile (not according to the invention), n-Heptane / n-Propanol / Acetonitrile (not according to the invention),n-Heptane / Dichloromethane / Acetonitrile (not according to the invention), n-Heptane / Dichloromethane / Methanol, n-Heptane / Tetrahydrofuran / Acetonitrile (not according to the invention), n-Heptane / Benzotrifluoride / Acetonitrile (not according to the invention), Cyclohexane / Methanol / Water (not according to the invention), Cyclohexane / Methanol / Acetonitrile (not according to the invention), Cyclohexane / T-Butylmethylether / Water (not according to the invention), Cyclohexane / Acetonitrile / Water (not according to the invention), Isooctane / Methanol (not according to the invention), Isooctane / Methanol / Water (not according to the invention), Isooctane / Ethylacetate / Methanol / Water (not according to the invention),
[0017] However, acetonitrile, optionally mixed with 1-15% t-butyl methyl ether (TBME), is particularly preferred.
[0018] Furthermore, it can be provided that the method according to the invention is carried out one or more times (see, for example, Example 1).
[0019] The selection of these solvents allows the extraction of cannabinoids, preferably Δ 9< THC and CBD, in high purity of more than 95%.
[0020] Therefore, a cannabis extract obtainable or obtained by the process according to the invention is also disclosed, wherein the dronabinol purity is more than 95%, in particular 99.6%.
[0021] Therefore, a cannabis extract obtainable or obtained by the process according to the invention is also disclosed, wherein the cannabidiol (CBD) purity is more than 95%, in particular 99.3%.
[0022] For the purposes of this invention, cannabinoids are understood to mean, in particular, the following substances: Cannabigerol-like (CBG): Cannabigerol ((E)-CBG-C 5 ), Cannabigerol Monomethylether ((E)-CBGM-C 5 A), Cannabinerolsäure A ((Z)-CBGA-C 5 A), Cannabigerovarin ((E)-CBGV-C 3 ), Cannabigerolsäure A ((E)-CBG-C 5), Cannabigerol Abigerol Monomethylether ((E)-CBGAM-C 5 A), Cannabigerovarin acid A ((E)-CBGVA-C 3 A) ; Cannabichromene-like (CBC): Cannabichromen (CBC-C 5 ), Cannabichromenic Acid A (CBCA-C 5 A), Cannabichromevarin (CBCV-C 3 ), Cannabichromevarin Acid A (CBCVA-C3 A); Cannabidiol-like (CBD) : Cannabidiol (CBD-C 5 ), Cannabidiol Monomethylether (CBDM-C 5 ), Cannabidiol-C4 (CBD-C 4 ), Cannabidivarin (CBDV-C 3 ), Cannabidiorcol (CBD-C 1 ), Cannabidiolsäure (CBDA-C 5 ), Cannabidivarinsäure (CBDVA-C 3); Cannabinodiol-like (CBND) : Cannabinodiol (CBND-C 5 ), Cannabinodivarin (CBND-C 3 ); Tetrahydrocannabinol-like (THC):Δ9-Tetrahydrocannabinol (Δ9-THC-C 5 ), Δ9-Tetrahydrocannabinol-C4 (Δ9-THC-C 4 ), Δ9-Tetrahydrocannabivarin (Δ9-THCV-C 3 ), Δ9-Tetrahydrocannabiorcol (Δ9-THCO-C 9 Δ9-Tetrahydrocannabinolsäure (Δ9-THCA-C 5 A), Δ9-Tetrahydrocannabinolsäure B (Δ9-THCA-C 5 B), Δ9-Tetrahydrocannabinolsäure-C4 (Δ9-THCAins-C 4 A und / oderbi Ahydra BTevar Δ9 (Δ9-THCVA-C 3 A), Δ9-Tetrahydrocannabiorcolsäure (Δ9-THCOA-C 1 A und / oder B), (-)-Δ8-trans-(6aR,10aR)-Δ8-Tetrahydrocannabinol (Δ8-THC-C 5 ), (-)-Δ8-trans-(6aR,10aR)-Tetrahydrocannabinolsäure A (Δ8-THCA-C 5 A); (-)-(6aS,10aR)-Δ9-Tetrahydrocannabinol ((-)-cis-Δ9-THC-C 5 ); Cannabinol-like (CBN): Cannabinol CBN-C 5 , Cannabinol-C4 (CBN-C 4 ), Cannabivarin (CBN-C 3 ), Cannabinol-C2 (CBN-C 2 ), Cannabiorcol (CBN-C 1 ), Cannabinolsäure A (CBNA-C 5 A), Cannabinolmethylether (5CBNM ) Cannabitriol-like (CBT):(-)-(9R,10R)-trans-Cannabitriol ((-)-trans-CBT-C 5 ), (+)-(9S,10S)-Cannabitriol ((+)-trans-CBT-C 5 ), (±)-(9R,10S / 9S,10R)-Cannabitriol ((±)-cis-CBT-C 5 ), (-)-(9R,10R)-trans[10-O-Ethyl-cannabitriol] ((-)-trans-CBT-OEt-C 5 ), (+)-(9R,10R / 9S,10S)-Cannabitriol-C 3 ((+)-trans-CBT-C 3 ),8,9-Dihydroxy-Δ6a(10a) tetrahydrocannabinol (8,9-Di-OH-CBT-C 5 ), Cannabidiolsäure A (CBDA-C 5 9-OH-CBT-C5 ester), (-)-(6aR,9S,10S,10aR)-9,10-Dihydroxy-hexahydrocannabinol, Cannabiripsol Cannabiripsol-C5, (-)-6a,7,10a-Trihydroxy-Δ9-tetrahydrocannabinol ((-)-Cannabitetrol), 10-Oxo-Δ6a(10a) tetrahydrocannabinol (OTHC); Cannabielsoin-like (CBE): (5aS,6S,9R,9aR)- C 5 -Cannabielsoin (CBE-C 5 ), (5aS,6S,9R,9aR)-C 3 -Cannabielsoin (CBE-C 3 ), (5aS,6S,9R,9aR)-Cannabielsoinsäure A (CBEA-C 5 A), (5aS,6S,9R,9aR)-Cannabielsoinsäure B (CBEA-C 5 B), (5aS,6S,9R,9aR)-C3-Cannabielsoinsäure B (CBEA-C 3 B), Cannabiglendol-C3 (OH-iso-HHCV-C 3 ), Dehydrocannabifuran (DCBF-C 5 ), Cannabifuran (CBF-C 5 ); Isocannabinoids:(-)-Δ7-trans-(1R,3R,6R)-Isotetrahydrocannabinol, (±)-Δ7-1,2-cis-(1R,3R,6S / 1S,3S,6R)-Isotetrahydrocannabivarin, (-)-Δ7-trans-(1R,3R,6R)-Isotetrahydrocannabivarin; Cannabicyclol-like (CBL): (±)-(1aS,3aR,8bR,8cR)-Cannabicyclol (CBL-C 5 ), (±)-(1aS,3aR,8bR,8cR)-Cannabicyclolsäure A (CBLA-C 5 A), (±)-(1aS,3aR,8bR,8cR)-Cannabicyclovarin (CBLV-C 3 ); Cannabicitran-like (CBT) : Cannabicitran (CBT-C 5 ) ; Cannabichromanone-like (CBCN) : Cannabichromanon (CBCN-C 5 ), Cannabichromanon-C3 (CBCN-C 3 ), Cannabicoumaronon (CBCON-C 5 ). Besonders bevorzugt sind jedoch Cannabidiol (CBD-C 5 ) und Δ9-Tetrahydrocannabinol (Δ9-THC-C 5 ).
[0023] The term "liquid-liquid partition chromatography step" in the context of the present invention refers in particular to chromatography which proceeds as follows: A specific amount of a substance mixture is passed through a stationary phase with a liquid mobile phase, which is held stationary by centrifugal force. In a further preferred embodiment, the liquid-liquid partition chromatography can be carried out continuously. For this purpose, the two phases are conducted in countercurrent, and a continuous separation is achieved instead of a time-delayed (discontinuous) discharge (see, for example, Yin, Lianhong; Li, Yingnan; Lu, Binan; Jia, Yujie; Peng, Jinyong, Trends in Counter-Current Chromatography: Applications to Natural Products Purification Separation and Purification Reviews (2010), 39(1-2), 33-62).
[0024] Depending on their varying strengths of interaction with the stationary phase, the substances emerge continuously or discontinuously and can be separated. However, while in liquid chromatography the stationary phase consists of a packed fixed bed in a column, in liquid-liquid partition chromatography there is a second immiscible liquid phase that is kept stationary by suitable devices, such as a rotor, using centrifugal force, in particular by means of a corresponding centrifugal partition chromatograph (see above).
[0025] "Cannabis extract" in the context of this invention means any processed extract from a cannabis or hemp plant containing cannabinoids. The extract can be a primary extract or a partially processed extract. The production of cannabis extracts is sufficiently described in the prior art. Suitable cannabis plants or (fiber) hemp plants include those such as drug hemp and fiber hemp.
[0026] In a further preferred embodiment, at least one preparative column (solid phase, such as silica gel) can be connected upstream or downstream (Example 2). Examples and figures:
[0027] These examples and figures serve solely to explain the invention without limiting the invention to these examples. Example 1: Cannabinoids from hemp
[0028] Extraction of THC (Dronabinol) ( Figure 1-7 ), CBD ( Figure 8 ) or CBC ( Figure 9) from drug hemp or industrial, fiber hemp: Extraction of cannabis flos using heptane, decarboxylation at 120°C in vacuum, dissolution in heptane, purification in the CPC. 1. CPC 1st run: quantitative separation of CBN, proportional separation of CBC:
[0029] Eluent: Acetonitrile TBME approx. 12% (not according to the invention). Stationary phase: Heptane TBME approx. 10% from dronabinol 84.1% with approx. 15.9% impurities, of which 5.4% is CBN and 2.2% is CBC. Color: deep brown to blackish. Figure 1 (not according to the invention)
[0030] The result is: Dronabinol 97.7% with approximately 2.3% impurities, of which 0.4% is CBN and 0.9% is CBC. Color: yellow. Figure 2 (not according to the invention)
[0031] Optional 2nd run: quantitative removal of CBC. Mobile phase: Acetonitrile TBME (approx. 12%). Stationary phase: Heptane TBME (approx. 10%) from dronabinol (97.7%) with approx. 2.3% impurities, of which 0.8% is CBN and 0.9% is CBC. Color: yellow. Figure 3 (not according to the invention)
[0032] The result is: Dronabinol 99.6% with approximately 0.4% impurities, of which 0.04% is CBN and 0.05% is CBC. Color: yellowish (further lightening possible) Figure 4 (not according to the invention)
[0033] Example 2: CPC with downstream run on a silica gel column. Run: quantitative separation of CBN, no separation of CBC. Mobile phase: pure acetonitrile. Stationary phase: pure heptane from 81% dronabinol with approximately 19% impurities, of which 4.2% is CBN and 1.6% is CBC. Color: blackish to deep brown. Figure 5 (not according to the invention)
[0034] The result is: Dronabinol 94.5% with approximately 5.5% impurities, of which 0.16% is CBN and 1.4% is CBC. Color: yellow. Figure 6 (not according to the invention)
[0035] Subsequent preparative chromatography on silica gel for quantitative separation of CBC: Flow agent: heptane 3% TBME from 96.4% dronabinol with approximately 3.6% impurities, of which 0.36% is CBN and 1.8% is CBC. Color: yellow. Figure 7 (not according to the invention)
[0036] The result is: Dronabinol 98.6% with approximately 1.4% impurities, of which 0.4% is CBN and 0.0% is CBC. Color: colorless. Figure 8 (not according to the invention) :
[0037] The result is: Cannabidiol 99.3% with approximately 0.7% impurities, of which 0.3% is CBN. Color: colorless, crystallizable Figure 9 (not according to the invention)
[0038] The result is: Cannabichromene 94.1% with approximately 5.9% impurities, with dronabinol being 3.39% and Δ8-THC being 0.19%.
Claims
1. A process for the separation and / or purification of cannabinoids from a cannabis extract, the process including at least one liquid-liquid partition chromatography step consisting of a first solvent phase and a second immiscible liquid phase, wherein the first solvent phase is n-heptane, which is kept stationary by centrifugal force, and the second immiscible liquid phase is methanol.
2. The process for the separation and / or purification of cannabinoids from a cannabis extract according to claim 1, wherein 1% to 15% (v / v) t-butyl methyl ether is added to the first solvent phase and / or the second immiscible liquid phase.
3. The process for the separation and / or purification of cannabinoids from a cannabis extract according to claim 2, wherein 9% to 13% (v / v) t-butyl methyl ether is added to the first solvent phase and / or the second immiscible liquid phase.
4. The process for the separation and / or purification of cannabinoids from a cannabis extract according to any one of claims 1 to 3, with a flow of 50 mL to 600 mL per minute and / or a rotational speed of 50 rpm to 1,500 rpm.
5. The process for the separation and / or purification of cannabinoids from a cannabis extract according to any one of claims 1 to 4, wherein the first solvent phase and the second immiscible liquid phase are passed in countercurrent and a continuous separation takes place.
6. The process for the separation and / or purification of cannabinoids from a cannabis extract according to any one of claims 1 to 5, wherein at least one preparative column is connected upstream or downstream.
7. The process for the separation and / or purification of cannabinoids from a cannabis extract according to any one of claims 1 to 6, wherein a centrifugal partition chromatograph is used for the separation and / or purification.
